Back to journals
Academic JournalOpen Access

Harm Reduction Journal

4 Papers Indexed in Blossom

Published Papers

Open Accessmeta

Ethical and legal issues in psychedelic harm reduction and integration therapy

The paper analyses the ethical and legal risks therapists face when supporting clients who use prohibited psychedelics and argues that a harm‑reduction framework enables clinicians to mitigate those risks. It recommends pre‑ and post‑experience sessions and practical strategies so therapists can help clients minimise harms and maximise therapeutic benefit while striving to remain within legal and ethical boundaries.

Published
Journal
Harm Reduction Journal
Authors
Pilecki, B., Luoma, J. B., Bathje, G. J., Rhea, J., Narloch, V. F.
Open Accessindividual

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube

Analysis of YouTube self‑reports and comments found that users predominantly describe therapeutic and enhancement benefits from psychedelic microdosing (mainly LSD and psilocybin), with notable improvements for depression and outcomes shaped by intentions and peer‑shared strategies. The study suggests microdosing may offer some benefits similar to full‑dose treatments with fewer acute adverse reactions, but repeated long‑term exposure could introduce additional risks.

Published
Journal
Harm Reduction Journal
Authors
Andersson, M., Kjellgren, A.
Paywallindividual

Psychedelic microdosing benefits and challenges: an empirical codebook

This survey study (n=278) aimed to develop a codebook of benefits and challenges associated with microdosing. The authors found, among other things, that many parallels exist between the effects reported as benefits and those reported as challenges.

Published
Journal
Harm Reduction Journal
Authors
Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L., Hui, K., Hapke, E.
Open Accessindividual

Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches

This qualitative study (2017) examined self-reports from online forums about psychoactive substance use for treating migraines and cluster headaches, and found that psychedelic tryptamines, primarily LSD and psilocybin, were frequently reported to lessen both their frequency and intensity of pain at sub-psychoactive doses.

Published
Journal
Harm Reduction Journal
Authors
Andersson, M., Persson, M., Kjellgren, A.

Quick Facts

Papers Indexed
4
h-Index
71
Open Access
Yes
Publisher
Springer Nature
Country
United Kingdom
Website
Visit